Member of the Board of Directors of the Novo Nordisk Foundation since 2005.
Most recently elected in March 2017 for a one-year term. Bo Ahrén is not considered to be an independent member.
Bo Ahrén was born in 1952. He was elected as a member of the Board of the Foundation with a medical background. He was a member of the Foundation’s Nordic Research Committee from 2001 to 2016 and chaired it from 2005 to 2016; a member of the Committee on the Novo Nordisk Prize from 2005 to 2016; a member of the Novo Nordisk Foundation Laureate Research Committee from 2012 to 2016; and Chair of the Novo Nordisk Foundation Committee on Exploratory Pre-seed Grants from 2010 to 2016.
Bo Ahrén received his MD degree in 1978 and his doctorate degree in 1981. Since 1985, he has been Professor of Clinical Metabolism, Department of Clinical Sciences, Faculty of Medicine, Lund University, Sweden. Since 2000, he has been a consultant in the Department of Endocrinology of Lund University Hospital. He was a Chief Physician in Region Skåne, Sweden in 2004–2005.
Bo Ahrén is an active researcher within diabetes. He has published more than 600 original scientific articles and review articles on insulin secretion. In the past couple of years, his research has concentrated on the function of incretin, with particular emphasis on developing novel treatments for type 2 diabetes based on the incretin hormone GLP-1.
Bo Ahrén was the Dean of the Faculty of Medicine of Lund University from 2006 to 2011 and was elected Pro Vice-chancellor of the University in 2015.
Experience in medical research, innovation and research leadership. Experience in university and hospital management and the framework conditions for research. Experience in research policy in medicine.
Active in research on endocrinology and diabetes. Focus on insulin secretion and the incretin hormone, with emphasis on developing treatments for type 2 diabetes based on the incretin hormone GLP-1.
Education and career
1999–: Professor of Clinical Metabolism, Lund University, Sweden
2006–2011: Dean, Faculty of Medicine, Lund University, Sweden
2004–2005: Chief Physician, Region Skåne, Sweden
2000–: Consultant, Department of Endocrinology, Skåne University Hospital, Sweden
1995–1999: Associate Professor of Clinical Metabolism, Lund University, Sweden
1984–2000: Clinician, Lund University Hospital and Malmö University Hospital, Sweden
1984–1985: Postdoctoral studies, Department of Endocrinology, University of Washington, United States
1981: PhD in pharmacology, Lund University, Sweden
1978: MD degree
Bo Ahrén has been a member of numerous councils, committees and scientific companies in Denmark and abroad, including the following.
2014–2016: Chair, Committee on the Novo Nordisk Foundation Challenge Programme
2014–2016: Member, Novo Nordisk Foundation Committee on the Interdisciplinary Synergy Programme
2011–2016: Member, Novo Nordisk Foundation Committee on Exploratory Pre-seed Grants
2009–2014: Chair, Medicon Valley Alliance
2005–2016: Chair, Novo Nordisk Foundation Nordic Research Committee
2012–2016: Member, Novo Nordisk Foundation Laureate Research Committee
2005–2016: Member, Committee on the Novo Nordisk Prize
Link to publications
Link to public CV